John C. McKew
2022
In 2022, John C. McKew earned a total compensation of $1.1M as President and Chief Scientific Officer at NewLink Genetics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $374,969 |
|---|---|
| Option Awards | $99,685 |
| Salary | $535,096 |
| Stock Awards | $15,030 |
| Other | $33,398 |
| Total | $1,058,178 |
McKew received $535.1K in salary, accounting for 51% of the total pay in 2022.
McKew also received $375K in non-equity incentive plan, $99.7K in option awards, $15K in stock awards and $33.4K in other compensation.
Rankings
In 2022, John C. McKew's compensation ranked 2,912th out of 5,760 executives tracked by ExecPay. In other words, McKew earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,912 out of 5,760 | 49th |
Division Manufacturing | 1,630 out of 3,136 | 48th |
Major group Chemicals And Allied Products | 761 out of 1,422 | 47th |
Industry group Drugs | 710 out of 1,323 | 46th |
Industry Pharmaceutical Preparations | 514 out of 969 | 47th |
Source: SEC filing on March 31, 2023.
McKew's colleagues
We found two more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2022.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020